With the drug-resistant forms of tuberculosis (TB) still a global health crisis and the number of persons receiving multi-drug resistant tuberculosis (MDR-TB) treatment globally remaining low, the World Health Organisation (WHO) and the Global Fund identified a funding of US$ 1.6 billion annually is
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
BusinessDay
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
